MERCURY LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Mercury Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.56₹ 4.65
As on Dec 19, 2025, 4:01 PM IST
Mercury Laboratories Price Performance
Today's LowToday's High
₹817.00₹829.80
₹829.80
52 Weeks' Low52 Weeks' High
₹736.00₹989.90
₹829.80
Open Price
₹817.00
Prev. Close
₹825.15
Volume
113
Over the last 5 years, the share price of Mercury Laboratories has gained 11.71% CAGR. Over the past year, the corresponding return has been -13.56%.
Mercury Laboratories’s current P/E of 20.26x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Mercury Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Mercury Laboratories | -0.65 | -4.95 | -1.33 | 0.58 | -13.56 | 3.97 | 11.71 |
| Sun Pharmaceutical Industries | -2.75 | -2.19 | 5.37 | 5.93 | -4.30 | 20.88 | 25.88 |
| Divi's Laboratories | 0.70 | 0.28 | 4.41 | -0.33 | 11.17 | 24.58 | 12.25 |
| Torrent Pharmaceuticals | 0.29 | 1.89 | 4.66 | 19.96 | 9.61 | 33.52 | 23.29 |
| Cipla | -0.01 | -0.61 | -3.71 | 2.28 | 0.74 | 11.43 | 14.29 |
| Dr. Reddy's Laboratories | 0.03 | 2.39 | -3.23 | -3.50 | -3.47 | 13.32 | 4.79 |
| Lupin | 0.48 | 4.90 | 3.31 | 9.92 | -1.75 | 42.86 | 17.96 |
| Zydus Lifesciences | -0.99 | -1.13 | -11.30 | -3.16 | -6.68 | 30.99 | 15.25 |
| Mankind Pharma | -0.25 | -2.21 | -18.30 | -6.40 | -24.76 | 15.14 | 8.83 |
| Aurobindo Pharma | 2.41 | -0.85 | 9.31 | 12.85 | -2.62 | 40.82 | 7.65 |
| Alkem Laboratories | -0.91 | -2.67 | 0.83 | 16.80 | 1.50 | 22.97 | 14.17 |
| Abbott India | 0.14 | -5.34 | -7.59 | -9.71 | -3.62 | 10.28 | 12.08 |
| Laurus Labs | 3.18 | 6.06 | 12.39 | 62.14 | 82.85 | 39.25 | 25.89 |
| Glenmark Pharmaceuticals | 0.85 | 8.18 | -4.50 | 21.40 | 29.27 | 68.48 | 32.41 |
| Biocon | 3.03 | -2.81 | 7.88 | 14.27 | 13.70 | 14.84 | -2.43 |
| GlaxoSmithKline Pharmaceuticals | -2.24 | 0.85 | -7.24 | -20.48 | 9.23 | 24.03 | 10.39 |
| Anthem Biosciences | -2.90 | 5.58 | -19.83 | -7.05 | -7.05 | -2.41 | -1.45 |
| Ipca Laboratories | -2.46 | -1.03 | 0.09 | 5.16 | -10.19 | 18.76 | 5.21 |
| Ajanta Pharma | -1.06 | 4.61 | 3.39 | 3.45 | -8.56 | 30.76 | 19.94 |
| J B Chemicals & Pharmaceuticals | -0.23 | 2.45 | 4.76 | 7.46 | -6.12 | 20.37 | 27.80 |
Over the last one year, Mercury Laboratories has declined 13.56% compared to peers like Sun Pharmaceutical Industries (-4.30%), Divi's Laboratories (11.17%), Torrent Pharmaceuticals (9.61%). From a 5 year perspective, Mercury Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (25.88%) and Divi's Laboratories (12.25%).
Mercury Laboratories Financials
Mercury Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 833.01 | 832.16 |
| 10 | 839.22 | 836.44 |
| 20 | 844.97 | 843.04 |
| 50 | 855.28 | 850.93 |
| 100 | 857.15 | 853.98 |
| 200 | 848.05 | 862.39 |
Mercury Laboratories Share Holding Pattern
In the latest quarter, Mercury Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 26.34% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Mercury Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 17, 2025, 11:49 PM IST | Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
| Nov 12, 2025, 1:02 AM IST | Mercury Laboratories - Updates On New Small Volume Parenteral (Svps) Plant At Jarod |
| Nov 12, 2025, 12:57 AM IST | Mercury Laboratories - Unaudited Financial Results For The Quarter And Half Year Ended On September 2025 |
| Nov 12, 2025, 12:46 AM IST | Mercury Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On November 11, 2025 |
| Nov 07, 2025, 9:55 PM IST | Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
About Mercury Laboratories
Mercury Laboratories Ltd. is a Public Limited Listed company incorporated on 12/02/1982 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L74239MH1982PLC026341 and registration number is 026341. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 75.10 Cr. and Equity Capital is Rs. 1.20 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressFirst Floor, 18, Shreeji Bhuvan, Mumbai Maharashtra 400002
- Contact
Management
- Mr. Sanjay PatelChairperson & Independent Director
- Mr. Rajendra R ShahManaging Director
- Ms. Janki R ShahNon Executive Director
- Mr. Paresh MistryNon Executive Director
- Mr. Dilip R ShahNon Executive Director
- Mr. Jayantilal D RavalInd. Non-Executive Director
FAQs on Mercury Laboratories Share Price
What is the share price of Mercury Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Mercury Laboratories is ₹829.80 as on Dec 19, 2025.
What kind of stock is Mercury Laboratories?
The Mercury Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Mercury Laboratories?
The market cap of Mercury Laboratories is ₹99.58 Cr as on Dec 19, 2025.
What are today's High and Low prices of Mercury Laboratories?
Today’s highest and lowest price of Mercury Laboratories are ₹829.80 and ₹817.00.
What are the 52 Week High and 52 Week Low of Mercury Laboratories?
The 52-week high/low is the highest and lowest price at which Mercury Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Mercury Laboratories is ₹989.90 and 52-week low of Mercury Laboratories is ₹736.00 as on Dec 19, 2025.
How has the Mercury Laboratories performed historically in terms of returns?
The Mercury Laboratories has shown returns of 0.56% over the past day, -4.95% for the past month, -1.33% over 3 months, -13.56% over 1 year, 3.97% across 3 years, and 11.71% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Mercury Laboratories?
P/E ratio of and PB ratio of Mercury Laboratories are 20.26 and 1.86 on Dec 19, 2025. While the company gives a dividend yield of 0.42 per annum.
✕
Market Pulse